After Lebanon withdrew public subsidies for immunotherapy drugs in October 2022, three quarters of patients with extensive small cell lung cancer at one Beirut hospital did not receive the recommended treatment, and access depended on how they paid.
Published as "Cancer Care in Crisis: How Subsidy Cuts Affected Immunotherapy Access for Patients With Small Cell Lung Cancer in Lebanon". A mixed-methods study at Hôtel-Dieu de France University Hospital, Beirut: an interview with the hospital pharmacy and a retrospective cohort of patients diagnosed with extensive-stage small cell lung cancer from 2019 to 2024.
Shows in one hospital how withdrawing public subsidy for immunotherapy in October 2022 turned access into a question of who could pay.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/